Industry News

Industry News

A child's gender influences symptoms of genetic disorder

Feb 11, 2014

A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1). Read More

Discovery of global regulator of mRNA editing

Feb 11, 2014

An international team of researchers, led by scientists from the University of California, San Diego School of Medicine and Indiana University, have identified a protein that broadly regulates how genetic information transcribed from DNA to messenger RNA (mRNA) is processed and ultimately translated into the myriad of proteins necessary for life. Read More

Discovery of global regulator of mRNA editing

Feb 11, 2014

An international team of researchers, led by scientists from the University of California, San Diego School of Medicine and Indiana University, have identified a protein that broadly regulates how genetic information transcribed from DNA to messenger RNA (mRNA) is processed and ultimately translated into the myriad of proteins necessary for life. Read More

Vitamin C may boost chemotherapy

Feb 10, 2014

A new study suggests giving some cancer patients high doses of vitamin C intravenously - as opposed to orally - alongside conventional chemotherapy, may help kill cancer cells and also reduce some of its toxic side effects. Read More

Vitamin C may boost chemotherapy

Feb 10, 2014

A new study suggests giving some cancer patients high doses of vitamin C intravenously - as opposed to orally - alongside conventional chemotherapy, may help kill cancer cells and also reduce some of its toxic side effects. Read More

Scripps Florida scientists invent breakthrough approach to quickly identify new drug candidates from genome sequence

Feb 10, 2014

In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of principle, they identified a highly potent compound that causes cancer cells to attack themselves and die. Read More

Researchers discover potential novel treatment against septic shock, one of the leading causes of mortality in intensive care unit

Feb 10, 2014

Septic shock is caused by excessive and systemic reaction of the entire body against infectious agents, in most cases of bacterial origin. The number of deaths by septic shock in intensive care units is very high and is still increasing, despite numerous large scale clinical trials. Read More

Researchers discover potential novel treatment against septic shock, one of the leading causes of mortality in intensive care unit

Feb 10, 2014

Septic shock is caused by excessive and systemic reaction of the entire body against infectious agents, in most cases of bacterial origin. The number of deaths by septic shock in intensive care units is very high and is still increasing, despite numerous large scale clinical trials. Read More

Device the size of a credit card could analyze biopsy, help diagnose pancreatic cancer in minutes

Feb 10, 2014

Pancreatic cancer is a particularly devastating disease. At least 94 percent of patients will die within five years, and in 2013 it was ranked as one of the top 10 deadliest cancers.Routine screenings for breast, colon and lung cancers have improved treatment and outcomes for patients with these diseases, largely because the cancer can be detected early. Read More

Daily aspirin use 'reduces ovarian cancer risk by 20%'

Feb 10, 2014

Previous research has suggested that aspirin may help to reduce the risk of breast cancer and melanoma. Now, new research from the National Institutes of Health suggests that women who take low-dose aspirin every day may reduce their risk of ovarian cancer by 20%.The findings were recently published in the Journal of the National Cancer Institute. Read More

Previous Page   Next Page